This journal is part of the respected BMC Series, a portfolio of journals renowned for their commitment to rigorous, transparent, and reproducible science in health, informatics, and decision-making.
The BMC Series has a long-standing reputation for quality and openness, offering trusted platforms such as BMC Medical Informatics and Decision Making, BMC Bioinformatics, and BMC Digital Health. By joining this series, BMC Personalized Medicine benefits from this legacy, ensuring researchers and readers can rely on the integrity and impact of the work we publish. The journal also supports transparent peer review and make editorial decisions based on the validity and rigor of a study rather than its perceived impact.
Interdisciplinary by design, BMC Personalized Medicine offers a platform for research focused on tailoring healthcare to the individual. The journal welcomes foundational and applied studies, from preclinical insights to real-world implementation, that examine how molecular profiles, digital tools, clinical data, and social and environmental factors inform personalized approaches to prevention, diagnosis, and treatment. Areas of interest include molecular biomarkers, multi-omics integration, disease risk stratification, remote health technologies, AI-based modeling, microbiome-informed care, emerging therapeutics, and the societal dimensions of personalization such as ethics, equity, and implementation.
Committed to sustainable development, BMC Personalized Medicine encourages research that promotes good health and wellbeing (SDG3) as well as reducing inequalities (SDG 10) by promoting equitable, individualized care strategies.
We are now actively recruiting editorial board members ahead of the official launch; to find out more about this or other ways to get involved in BMC Personalized Medicine, please get in touch; we would love to hear from you! My email is alison.cuff@biomedcentral.com